方盛制药：关于洛索洛芬钠凝胶贴膏获得《药品注册证书》的公告

Core Viewpoint - Fangsheng Pharmaceutical announced that its wholly-owned subsidiary, Guangdong Fangsheng Jianmeng Pharmaceutical Co., Ltd., received the drug registration certificate for Loxoprofen Sodium Gel Patch from the National Medical Products Administration, indicating a significant regulatory approval for a new product aimed at treating osteoarthritis pain and inflammation [1] Group 1 - The product, Loxoprofen Sodium Gel Patch, is specified to contain 100 mg of Loxoprofen Sodium per patch, with dimensions of 14 cm x 10 cm and a total gel weight of 10 g [1] - The drug has been approved under the national drug approval number H20263068 and does not require consistency evaluation, which may streamline its market entry [1]